An official website of the United States government
ExoDx Prostate Evaluation in Active Surveillance Patient Population
Trial Status: active
The goal of this observational study is to test whether the ExoDx Prostate test add value
in biopsy decision making to patients with prostate cancer on an active surveillance
regimen.
Inclusion Criteria
Male, 45+ years of age diagnosed with low-grade or favorable-intermediate prostate cancer and on an active surveillance regimen
Exclusion Criteria
Clinical symptoms of urinary tract infection at time of enrollment.
History of invasive treatment for benign prostatic hypertrophy with in 6 months of enrollment.
Known hepatitis or HIV
History of concurrent renal/bladder tumors
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05572099.
Locations matching your search criteria
United States
Florida
Miami
University of Miami Miller School of Medicine-Sylvester Cancer Center
Status: Active
Name Not Available
Maryland
Baltimore
Johns Hopkins University/Sidney Kimmel Cancer Center
Status: Active
Name Not Available
North Carolina
Durham
Duke University Medical Center
Status: Active
Name Not Available
The current trial seeks to evaluate the role of the ExoDx Prostate test in men with low
and favorable intermediate prostate cancer undergoing an active surveillance regimen.
